Yifan Pharmaceutical Co., Ltd. (002019.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 14.57B |
| Enterprise Value | 15.94B |
| P/E Ratio | 36.04 |
| PEG Ratio | -1.3 |
| Price/Sales Ratio | 2.28 |
| Price/Book Ratio | 1.26 |
| Enterprise/Revenue | 2.67 |
| Enterprise/EBITDA | 22.81 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.06 |
| Operating Margin | 0.08 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.04 |
Income Statement
| Revenue | 5.13B |
| Revenue/Share | 4.07 |
| Gross Profit | 2.41B |
| EBITDA | 825.51M |
| Net Income | 402.02M |
| Diluted EPS | 0.33 |
Balance Sheet
| Total Cash | 1.04B |
| Total Cash/Share | 0.86 |
| Total Debt | 2.96B |
| Total Debt/Equity | 0.33 |
| Current Ratio | 1.54 |
| Book Value Per Share | 7.19 |
Price History
| 52-Week Change | -29.86 |
| 52-Week High | 14.73 |
| 52-Week Low | 8.99 |
| Moving Average 50 Days | 9.41 |
| Moving Average 200 Days | 10.77 |
Statistics
| Average Volume | 10.01M |
| Shares Outstanding | 1.22B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.1 |
| Trailing Annual Dividend Yield | 1.08 |
| Payout Ratio | 0.56 |
| Last Split Factor | 5:2 |
| Last Split Date | May 16, 2016 |
AD
